The effectiveness of Chinese vaccines against coronavirus is low and the governing body is considered to be combinatorial, according to which it dominates the maximum authority of the Chinese disease control agency, in an unusual official admission of the disability of Chinese vaccines.
The Chinese pharmacies “do not have very high protection bags”, said the director of the Chinese Control Centers, Gao Fu, at a conference on Saturday in the Chengdu Surrounding City.
Beijing has distributed tens of thousands of doses in other countries and has tried to focus on dudes in the efficiency of western vacancies.
“Now we are officially considering whether we should use different technical lines for the immunization process,” said Gao.
Beijing has not approved any foreign exchange for its use in China.
Gao does not give details of possible changes in the strategy, but mentions the ARN message, an experimental technology used by western car manufacturers, while the Chinese pharmaceuticals are implementing technical techniques.
“Everybody needs to consider the benefits that can be given to the humanity of ARN’s vacancies,” he said. “We need to be careful and do not ignore it because we have different types of vacancies.”
Gao has been questioned in the past about the safety of ARN messenger vehicles. The Xinhua News Agency in December issued a statement stating that it would not disclose any negative secondary effects since it was the first time the vacancies had been settled.
Officials holding a conference press conference today will not immediately answer questions about Gao’s comments about possible changes in official plans. Pero another member of the signal control center who is working on ARN messenger vehicles.
“ARN’s vacancies were unrolled in our country as well during the clinical trial phase,” said official Wang Huaqing, who did not give up on his possible distribution.
Chinese media outlets and popular blogs on health and health have also questioned the safety and effectiveness of the Pfizer vaccine, which uses ARN messenger.
By April 2, 34 million people had received the required dose of Chinese vacancies, while 65 million people had received one dose, according to Gao.
The experts signal that measuring vacancies, or sequential munitions, can boost efficiency measures. Various studies in different parts of the world study the effect of measuring the vacancies or administering a recording dose over a long period of time. Investigators in Great Britain are studying a possible combination of Pfizer and AstraZeneca vehicles.
The coronavirus pandemic, which kicked off in the center of China in the 2019 finals, planted the first occasion in which the Chinese pharmaceutical industry played a key role in responding to global sanitation emergencies.
The vehicles manufactured by the state pharmaceuticals, Sinovac and Sinpopharm, were exported to 22 countries, such as Mexico, Turkey, Indonesia, Hungary, Brazil and Turkey, according to the Ministry of Exteriors.
Investigators in Brazil conclude that the effectiveness of a Sinovac vaccine to prevent 50.4% of early-onset bacterial infections, 50% of the umbilical cord, which experts consider a vaccine. And compare the low of Pfizer-BioNTech an effective share of 97%.
Sanitary experts are unlikely that Chinese vacancies will be sold in the United States, Western Europe and Japan as a matter of legal approval.